The DOI matches its Crossref record.
Tumour imaging by Positron Emission Tomography using fluorinase generated 5-[18F]fluoro-5-deoxyribose as a novel tracer
Abstract
Introduction 5-[(18)F]Fluoro-5-deoxyribose ([(18)F]FDR) 3 was prepared as a novel monosaccharide radiotracer in a two-step synthesis using the fluorinase, a C-F bond forming enzyme, and a nucleoside hydrolase. The resulting [(18)F]FDR 3 was then explored as a radiotracer for imaging tumours (A431 human epithelial carcinoma) by positron emission tomography in a mice model. Methods 5-[(18)F]Fluoro-5-deoxyribose ([(18)F]FDR) 3, was prepared by incubating S-adenosyl-L-methionine (SAM) and [(18)F]fluoride with the fluorinase enzyme, and then incubating the product of this reaction, [(18)F]-5'-fluoro-5'-deoxadenosine ([(18)F]FDA) 2, with an adenosine hydrolase to generate [(18)F]FDR 3. The enzymes were freeze-dried and were used on demand by dissolution in buffer solution. The resulting [(18)F]FDR 3 was then administered to four mice that had tumours induced from the A431 human epithelial carcinoma cell line. Results The tumour (A431 human epithelial carcinoma) bearing mice were successfully imaged with [(18)F]FDR 3. The radiotracer displayed good tumour imaging resolution. A direct comparison of the uptake and efflux of [(18)F]FDR 3 with 2-[(18)F]fluoro-2-deoxyglucose ([(18)F]FDG) was made, revealing comparative tumour uptake and imaging potential over the first 10-20min. The study revealed however that [(18)F]FDR 3 does not accumulate in the tumour as efficiently as [(18)F]FDG over longer time periods. Conclusions [(18)F]FDR 3 can be rapidly synthesised in a two enzyme protocol a…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nonetheless, fluorinase has been successfully leveraged in biosynthetic pathways to produce a variety of simple organofluorines used as PET tracers and medical imaging agents58–60.”
From The link between ancient microbial fluoride resistance mechanisms and bioengineering organofluorine degradation or synthesis (2024) · cites this paper as [60]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 24
- Townsend, 2008, Multimodality imaging of structure and function, Phys Med Biol, 53, R1, 10.1088/0031-9155/53/4/R01 · DOI
- Sharma, 2011, Development of radiotracers for oncology — the interface with pharmacology, Brit J Pharmacol, 163, 1565, 10.1111/j.1476-5381.2010.01160.x · DOI
- Bohnen, 2012, Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature, J Nucl Med, 53, 59, 10.2967/jnumed.111.096578 · DOI
- Cavalcanti Filho, 2011, PET/CT and vascular disease: current concepts, Eur J Radiol, 80, 60, 10.1016/j.ejrad.2010.12.102 · DOI
- Cai, 2008, Chemistry with [18F] fluoride ion, Eur J Org Chem, 2008, 2853, 10.1002/ejoc.200800114 · DOI
- Dong, 2004, Crystal structure and mechanism of a bacterial fluorinating enzyme, Nature, 427, 561, 10.1038/nature02280 · DOI · Paper page
- O'Hagan, 2002, Enzyme catalysed organofluorine synthesis, Nature, 416, 279, 10.1038/416279a · DOI
- Li, 2012, [18F]-5-fluoro-5-deoxyribose, an efficient peptide bioconjugation ligand for positron emission tomography (PET) imaging, Chem Commun, 48, 5247, 10.1039/c2cc31262j · DOI
- Onega, 2010, An enzymatic route to 5-deoxy-5-[18F] fluoro-D-ribose, a [18F] fluorinated sugars for PET imaging, Chem Commun, 139, 10.1039/B919364B · DOI
- Li, 2010, Fluorinase mediated chemoenzymatic synthesis of [18F]-fluoroacetate for PET studies, Chem Commun, 46, 7819, 10.1039/c0cc02264k · DOI
- Onega, 2009, The fluorinase: a tool for the synthesis of fluorine-18 labelled sugars and nucleosides for positron emission tomography, Future Med Chem, 1, 865, 10.4155/fmc.09.74 · DOI
- Winkler, 2008, Fluorinase coupled enzymatic base swaps generate 5′-deoxy-5′-fluoronucleosides from fluoride ion: synthesis of [18F]-5′-deoxy-5′-fluorouridines, AngewChemInt, 47, 10141
- Deng, 2006, Fluorinase mediated C-18F bond formation, an enzymatic tool for PET labelling, Chem Commun, 111, 652, 10.1039/b516861a · DOI
- Huang, 2009, Whole body PET/CT scanning. Estimation of radiation dose and cancer risk, Radiology, 251, 166, 10.1148/radiol.2511081300 · DOI
- Terasawa, 2008, 18F-FDG PET for post therapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: a systematic review, J Nucl Med, 49, 13, 10.2967/jnumed.107.039867 · DOI
- Ashton, 2005, An improved synthesis of 5′-fluoro-5′-deoxyadenosines, Bioorg Med Chem Lett, 15, 3361, 10.1016/j.bmcl.2005.05.029 · DOI
- Sharma, 1995, Synthesis of 5′-fluoro-5′-deoxy- and 5′-amino-5′-deoxytoyocamycin and sangivamycin and some related derivatives, Nucleosides Nucleotides, 14, 1831, 10.1080/15257779508010707 · DOI
- Versées, 2001, Structure and function of a novel purine specific nucleoside hydrolase from Trypanosoma vivax, J Mol Biol, 307, 1363, 10.1006/jmbi.2001.4548 · DOI
- Iovane, 2008, Arabidopsis thaliana nucleosidase mutants provide new insights into nucleoside degradation, Biochemistry, 47, 4418, 10.1021/bi702448s · DOI
- Windhorst, 2001, A complete, multipurpose, low cost, fully automated and GMP compliant radiosynthesis system, J Labelled Comp Radiopharm, 44, S1052, 10.1002/jlcr.25804401375 · DOI
- Theobald, 1995, Annexin VI has tumour-suppressor activity in human A431 squamous epithelial carcinoma cells, Br J Cancer, 71, 86, 10.1038/bjc.1995.152 · DOI
- Fan, 2012, P53 activation plays a crucial role in silibinin induced ROS generation via PUMA and JNK, Free Radic Res, 46, 310, 10.3109/10715762.2012.655244 · DOI
- Kuwabara, 1991, Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate, J Nucl Med, 32, 692
- Naula, 2010, A glucose transporter can mediate ribose uptake. Definition of residues that confer substrate specificity in a sugar transporter, J Biol Chem, 285, 29721, 10.1074/jbc.M110.106815 · DOI
Cited by
Sorted by citations
Stockbridge, R. B., & Wackett, L. P. (2024) · Nature Communications · doi:10.1038/s41467-024-49018-1 · Cited by 80
Metadata
- Authors
- Dall'Angelo, S., Bandaranayaka, N., Windhorst, A. D., Vugts, D. J., van der Born, D., Onega, M., Schweiger, L. F., Zanda, M., & O'Hagan, D.
- Venue
- Nuclear Medicine and Biology
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 40
- Issue
- 4
- Pages
- 464-470
- ISSN
- 0969-8051
- Cited by
- 31
- References
- 0
- Language
- en
- Funders
- Scottish Imaging Network a Platform for Excellence (SINAPSE)
- BBSRC (BB/F007426/1, BBSRC BB/FOF/310)
- ERC
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review